College webinar – New Advances in Heart Failure: what to expect in 2021
02 Dec 2020
We will host an outstanding programme of heart failure and new advances and future direction. Two respected and hugely admired world-class figures will share the stage. Marc Pfeffer and John McMurray will deliver an outstanding event on Wednesday 9 December.
Two of the prominent cardiology experts will discuss new advances in heart failure during the Royal College of Physicians and Surgeons of Glasgow’s new webinar at 6.30pm (GMT) on Wednesday 9 December 2020.
Professor Marc Pfeffer, a distinguished Dzau Professor of Medicine at Harvard Medical School, will speak about 2020 therapies for heart failure. Professor John McMurray, Professor of Medical Cardiology and Deputy Director (Clinical) of the Institute of Cardiovascular and Medical Sciences, will focus on 2021 therapies for heart failure.
Speaking ahead of the webinar, College Vice President (Medical) and President of the Scottish Cardiac Society, Professor Hany Eteiba said:
“We will host an outstanding programme of heart failure and new advances and future direction. Two respected and hugely admired world-class figures will share the stage. Marc Pfeffer and John McMurray will deliver an outstanding event on Wednesday 9 December.
“Attendees can share their views, comments and questions. This will undoubtedly enrich the educational value of this event.”
Places on New Advances in Heart Failure: what to expect in 2021 can be booked through our website.
Full biographies of the speakers are below:
Dr Marc Pfeffer is a cardiovascular medicine specialist at Brigham and Women’s Hospital and the Victor J. Dzau Professor of Medicine at Harvard Medical School. Dr Pfeffer received his medical degree from University of Oklahoma College of Medicine. He completed an internal medicine residency and a cardiology fellowship at Peter Bent Brigham Hospital. Dr Pfeffer is board certified in internal medicine, cardiovascular disease and advanced heart failure and transplant cardiology.
Dr Pfeffer, along with Dr Janice Pfeffer and Dr Eugene Braunwald, is credited with introducing the concept that angiotensin-converting enzyme inhibitors (ACEIs) could mitigate adverse ventricular remodeling following myocardial infarction and that ACEI use would result in increased survival and other clinical benefits.
His clinical interests include cardiovascular disease, congestive heart failure, coronary artery disease and valvular heart disease. The author of over 450 peer-reviewed publications, he has received research funding from the American Heart Association and National Institutes of Health. Dr Pfeffer has been listed as one of America’s Top Doctors by Castle Connolly and named a top cardiologist by Boston Magazine. Dr Pfeffer is the recipient of the Clinical Research Prize and the James Herrick Award, both from the American Heart Association.
Professor John McMurray graduated from Manchester University with Bsc (Hons) in 1980 and MB ChB (Hons) in 1983. He undertook a period of postgraduate research at the University of Dundee, with award of his research MD in 1990. He then trained in Medicine and Cardiology in Manchester, Edinburgh, Dundee and Glasgow and was appointed as Consultant Cardiologist in Edinburgh in 1993, before moving to Glasgow in 1995.
He is now Professor of Medical Cardiology and Deputy Director of the Institute of Cardiovascular and Medical Sciences at the University of Glasgow, UK and honorary Consultant Cardiologist at the Queen Elizabeth University Hospital, Glasgow.
Professor McMurray is a Fellow of the European Society of Cardiology, American College of Cardiology and American Heart Association as well as the Medical Royal Colleges in Edinburgh and Glasgow and the Royal Society of Edinburgh and UK Academy of Medical Sciences. He has lectured widely and won several awards, including the Stokes Medal of the Irish Cardiac Society.
His main research activity is clinical trials and he is a member of the executive committee or steering committee member in a number of large trials in heart failure, other cardiovascular diseases, renal disease and diabetes. In 2013, Professor McMurray was identified as one of the 400 most influential biomedical researchers in the world and the only cardiovascular researcher on this list from the UK. He has also been included in the 2014, 2016, 2017 and 2018 Highly Cited Researchers listing and one of The World’s Most Influential Scientific Minds.
This webinar is designed as an introduction to the virtual Interactive Cardiology Conference, which will take place over four evening webinars in March 2021. Those who have secured their place at the virtual conference in March 2021 will be given access automatically to this webinar.
Latest news and statements
Key priority areas
- Equality, Diversity and Inclusion
- Climate Change
- Health Inequalities
Tweets by @rcpsglasgow